Shares of Cassava Sciences are sinking after a former Securities and Exchange Commission enforcement lawyer filed a Citizen Petition, questioning the “quality and integrity” of the company’s Alzheimer’s study data. Lawyer Jordan Thomas of Labaton Sucharow alleged that some of Cassava’s results appeared to show signs of data manipulation. Cassava Sciences this morning issued a press release denying the allegations. The stock is down 29% to $84.18 in early trading.
previous post